Professional Medical Expertise Company SJSC 9574.SR · SAR
Health Care · Tadawul · 🇸🇦 Saudi Arabia
79.90
—
Close of 9 Nov 2026, in SAR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in SAR, from our data supplier.
Revenue
SAR 418.8m
FY2020FY2025
Net income
SAR 41.7m
FY2020FY2025
Free cash flow
−SAR 34.4m
FY2020FY2025
Shareholders' equity
SAR 150.2m
FY2020FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Revenue | SAR 418.8m | SAR 313.2m | SAR 250.1m | SAR 176.1m | SAR 131.3m | SAR 74.4m |
| Gross profit | SAR 176.4m | SAR 133.9m | SAR 112.0m | SAR 80.6m | SAR 64.5m | SAR 37.9m |
| Operating income | SAR 59.6m | SAR 39.7m | SAR 33.3m | SAR 26.0m | SAR 24.5m | SAR 11.6m |
| Net income | SAR 41.7m | SAR 27.7m | SAR 24.8m | SAR 19.0m | SAR 20.6m | SAR 9.3m |
| Diluted earnings per share | 11.92 | 7.90 | 7.10 | 5.43 | 5.89 | 2.66 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Total assets | SAR 422.6m | SAR 321.1m | SAR 279.3m | SAR 199.2m | SAR 165.1m | SAR 115.0m |
| Cash and short-term investments | SAR 3.8m | SAR 4.9m | SAR 951,865 | SAR 5.3m | SAR 17.8m | SAR 5.4m |
| Total liabilities | SAR 272.4m | SAR 207.9m | SAR 182.1m | SAR 126.0m | SAR 125.3m | SAR 91.1m |
| Debt | SAR 125.7m | SAR 95.5m | SAR 64.4m | SAR 58.5m | SAR 37.9m | SAR 36.8m |
| Shareholders' equity | SAR 150.2m | SAR 113.2m | SAR 97.2m | SAR 73.2m | SAR 39.8m | SAR 23.9m |
| Shares outstanding | 4m | 4m | 4m | 4m | 4m | 4m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Cash from operations | −SAR 10.2m | −SAR 1.9m | SAR 5.9m | −SAR 8.3m | SAR 18.5m | SAR 10.7m |
| Capital spending | −SAR 24.2m | −SAR 6.6m | −SAR 9.0m | −SAR 6.5m | −SAR 3.3m | −SAR 2.1m |
| Free cash flow | −SAR 34.4m | −SAR 8.5m | −SAR 3.1m | −SAR 14.8m | SAR 15.2m | SAR 8.7m |
| Dividends paid | −SAR 3.5m | −SAR 10.0m | — | −SAR 16.0m | −SAR 2.9m | −SAR 17.1m |
Latest quarters
By quarter end
| Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sept 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | SAR 95.0m | SAR 95.0m | SAR 81.9m | SAR 81.9m | SAR 74.7m | SAR 74.7m | SAR 65.7m | SAR 65.7m |
| Gross profit | SAR 42.5m | SAR 42.5m | SAR 37.2m | SAR 37.2m | SAR 32.2m | SAR 32.2m | SAR 29.5m | SAR 29.5m |
| Operating income | SAR 13.6m | SAR 13.6m | SAR 11.1m | SAR 11.1m | SAR 9.5m | SAR 9.5m | SAR 9.6m | SAR 9.6m |
| Net income | SAR 11.1m | SAR 11.1m | SAR 7.8m | SAR 7.8m | SAR 6.1m | SAR 6.1m | SAR 7.8m | SAR 7.8m |
| Diluted earnings per share | 3.16 | 3.16 | 2.22 | 2.22 | 1.73 | 1.73 | 2.24 | 2.24 |
| Cash from operations | SAR 1.0m | SAR 1.0m | SAR 5.0m | SAR 5.0m | −SAR 6.0m | −SAR 6.0m | SAR 8.0m | SAR 8.0m |
| Capital spending | −SAR 6.0m | −SAR 6.0m | −SAR 1.0m | −SAR 1.0m | −SAR 2.0m | −SAR 2.0m | −SAR 2.0m | −SAR 2.0m |
| Free cash flow | −SAR 5.0m | −SAR 5.0m | SAR 4.0m | SAR 4.0m | −SAR 8.0m | −SAR 8.0m | SAR 6.0m | SAR 6.0m |
| Total assets | SAR 384.1m | SAR 384.1m | SAR 321.1m | SAR 321.1m | SAR 307.1m | SAR 307.1m | SAR 279.3m | SAR 279.3m |
| Cash and short-term investments | SAR 7.2m | SAR 7.2m | SAR 4.9m | SAR 4.9m | SAR 7.4m | SAR 7.4m | SAR 951,865 | SAR 951,865 |
| Debt | SAR 108.7m | SAR 108.7m | SAR 92.4m | SAR 92.4m | SAR 99.1m | SAR 99.1m | SAR 61.8m | SAR 61.8m |
| Shareholders' equity | SAR 131.8m | SAR 131.8m | SAR 113.2m | SAR 113.2m | SAR 99.3m | SAR 99.3m | SAR 97.2m | SAR 97.2m |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 33.5% | 41.3% | — |
| Operating income | 31.8% | 38.6% | — |
| Net income | 29.9% | 35.0% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 42.4% | 43.4% | 44.4% | — |
| Operating margin | 13.6% | 13.7% | 14.3% | — |
| Net margin | 9.5% | 9.8% | 10.5% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Price to earnings | 8.1 | 11.4 | 10.1 |
| Price to sales | 0.8 | 1.0 | 1.0 |
Dividends and splits
Per share, in the currency the company pays
Paid for 3 years. Last went ex-dividend on 25 Jun 2025.
| FY2025 | FY2023 | |
|---|---|---|
| Paid in the year | 1.00 | 5.70 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.